These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 5549064)

  • 21. Species-dependent differences in recovery of 3,4-dihydroxybenzylamine in assays of plasma catecholamines.
    Garty M; Steinmetz Y; Rosenfeld JB; Goldstein DS
    J Chromatogr; 1988 Aug; 430(1):123-7. PubMed ID: 3145939
    [No Abstract]   [Full Text] [Related]  

  • 22. 3,4-dihydroxyphenylalanine (DOPA) decarboxylase deficiency and resultant high levels of plasma DOPA and dopamine in unfavorable neuroblastoma.
    Ikeda H; Matsuyama S; Suzuki N; Takahashi A; Kuroiwa M
    Hypertens Res; 1995 Jun; 18 Suppl 1():S209-10. PubMed ID: 8529065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The conversion of exogenously administered L-DOPA to dopamine in the stomach and liver of rats.
    Osumi Y; Wada I; Fujiwara M
    Jpn J Pharmacol; 1972 Oct; 22(5):723-6. PubMed ID: 4539790
    [No Abstract]   [Full Text] [Related]  

  • 24. Dopa in plasma increases during acute exercise and after exercise training.
    Devalon ML; Miller TD; Squires RW; Rogers PJ; Bove AA; Tyce GM
    J Lab Clin Med; 1989 Sep; 114(3):321-7. PubMed ID: 2504856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A specific radioenzymatic assay for dihydroxyphenylalanine (DOPA). Plasma dopa may be the precursor of urine free dopamine.
    Brown MJ; Dollery CT
    Br J Clin Pharmacol; 1981 Jan; 11(1):79-83. PubMed ID: 6783056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma levels of dihydroxyphenylalanine, dopamine and norepinephrine in the fetoplacental unit and maternal circulation at delivery.
    Yamamoto K; Shirai T; Katoh S; Yasuda A; Kitao M
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Dec; 40(12):1894-8. PubMed ID: 3145319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distribution of catecholamines between fetal and maternal compartments during human pregnancy with emphasis on L-dopa and dopamine.
    Peleg D; Munsick RA; Diker D; Goldman JA; Ben-Jonathan N
    J Clin Endocrinol Metab; 1986 May; 62(5):911-4. PubMed ID: 3958127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Catecholamines and memory: enhanced verbal learning during L-DOPA administration.
    Murphy DL; Henry GM
    Psychopharmacologia; 1972; 27(4):319-26. PubMed ID: 4648617
    [No Abstract]   [Full Text] [Related]  

  • 29. Alternative catecholamine pathways after tyrosine hydroxylase inhibition in malignant pheochromocytoma.
    Kuchel O; Buu NT; Edwards DJ
    J Lab Clin Med; 1990 Apr; 115(4):449-53. PubMed ID: 1969915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simultaneous analysis of human plasma catecholamines by high-performance liquid chromatography with a reversed-phase triacontylsilyl silica column.
    Machida M; Sakaguchi A; Kamada S; Fujimoto T; Takechi S; Kakinoki S; Nomura A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jan; 830(2):249-54. PubMed ID: 16301006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simultaneous measurement of urinary and plasma norepinephrine, epinephrine, dopamine, dihydroxyphenylalanine, and dihydroxyphenylacetic acid by coupled-column high-performance liquid chromatography on C8 and C18 stationary phases.
    Benedict CR
    J Chromatogr; 1987 Jan; 385():369-75. PubMed ID: 3104375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolism and absorption of L-3,4 dihydroxyphenylalanine in patients with Parkinson's disease.
    Bianchine JR; Calimlim LR; Morgan JP; Dujuvne CA; Lasagna L
    Ann N Y Acad Sci; 1971 Jul; 179():126-40. PubMed ID: 5285373
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of prolonged intravenous infusion of gludopa in humans and a preliminary study of its oral bioavailability.
    Freestone S; Ellis R; MacDonald TM; Lee MR
    Am J Hypertens; 1990 Jun; 3(6 Pt 2):126S-129S. PubMed ID: 2116808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dihydroxyphenylalanine (DOPA) in plasma during dopa treatment of patients with Parkinson's disease.
    Tyce GM; Muenter MD; Owen CA
    Mayo Clin Proc; 1970 Jun; 45(6):438-43. PubMed ID: 5425103
    [No Abstract]   [Full Text] [Related]  

  • 35. [Changes in biogenic amines in the early period after kidney allotransplantation].
    Arkhangel'skaia SL; Bilenko MV; Orzhekhovskaia IG; Polosina OV; Tsypin AB
    Patol Fiziol Eksp Ter; 1983; (4):64-8. PubMed ID: 6415604
    [No Abstract]   [Full Text] [Related]  

  • 36. [Changes in the content of eosinophils, corticosterone and catecholamines during liver regeneration following resection].
    Malyshev VV; Treshchuk LI; Popova NS
    Biull Eksp Biol Med; 1978 Dec; 86(12):663-4. PubMed ID: 728601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liquid chromatographic method for monitoring therapeutic concentrations of L-dopa and dopamine in serum.
    Riggin RM; Alcorn RL; Kissinger PT
    Clin Chem; 1976 Jun; 22(6):782-4. PubMed ID: 1277462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peripheral aromatic L-amino acids decarboxylase inhibitor in parkinsonism. II. Effect on metabolism of L-2- 14 C-dopa.
    Bianchine JR; Messiha FS; Hsu TH
    Clin Pharmacol Ther; 1972; 13(4):584-94. PubMed ID: 5042372
    [No Abstract]   [Full Text] [Related]  

  • 39. Metabolites of 6-[18F]fluoro-L-dopa in human blood.
    Firnau G; Sood S; Chirakal R; Nahmias C; Garnett ES
    J Nucl Med; 1988 Mar; 29(3):363-9. PubMed ID: 3126278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopamine and catecholamines in cystic fibrosis in response to a marathon race.
    Kollberg H; Schöni M; Türler K; Käser H; Bardón A; Ceder O; Stanghelle JK; Maehlum S; Skyberg D
    Int J Sports Med; 1988 Feb; 9 Suppl 1():56-9. PubMed ID: 3360546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.